Vera Hoffman, MBA

Vera Hoffman is the CEO and co-founder of Reveal Pharmaceuticals. She has directed startups and high growth enterprises from idea stage through global scale, and led Reveal since inception. Vera guided the design, development, and commercialization of over a dozen innovative technology-based products; led teams across six continents to identify, plan, and execute new business opportunities for one of the world's largest companies; and developed the initial business plan for Acquia ($1B exit, 2019). Vera is Principal Investigator of Reveal's multiple SBIR grants, which are funded by the National Cancer Institute, the National Institute for Diabetes and Digestive and Kidney Diseases, and the National Heart, Lung and Blood Institute. She has degrees in Chemistry and Mathematics and an MBA from Harvard Business School.